Molecular genetics of vascular malformations

Attisano, 1993, Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors, Cell, 75, 671, 10.1016/0092-8674(93)90488-C

Barbara, 1999, Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor- beta superfamily, J. Biol. Chem., 274, 584, 10.1074/jbc.274.2.584

Boon, 1999, A gene for inherited cutaneous venous anomalies (‘glomangiomas’) localizes to chromosome 1p21–22, Am. J. Hum. Genet., 65, 125, 10.1086/302450

Boon, 1994, Assignment of a locus for dominantly inherited venous malformations to chromosome 9p, Hum. Mol. Genet., 3, 1583, 10.1093/hmg/3.9.1583

Bourdeau, 1999, A murine model of hereditary hemorrhagic telangiectasia, J. Clin. Invest., 104, 1343, 10.1172/JCI8088

Brouillard, 2000, High resolution physical and transcript map of the locus for venous malformations with ‘glomus’ cells (VMGLOM) on chromosome 1p21–22, Genomics, 67, 96, 10.1006/geno.2000.6232

Calvert, 1999, Allelic and locus heterogeneity in inherited venous malformations, Hum. Mol. Genet., 8, 1279, 10.1093/hmg/8.7.1279

Craig, 1998, Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15–13 and 3q25.2-27, Hum. Mol. Genet., 7, 1851, 10.1093/hmg/7.12.1851

Dale, 1985, The inheritance of primary lymphoedema, J. Med. Genet., 22, 274, 10.1136/jmg.22.4.274

Dervan, 1989, Glomus tumours: an immunohistochemical profile of 11 cases, Histopathology, 14, 483, 10.1111/j.1365-2559.1989.tb02184.x

Dubovsky, 1995, A gene responsible for cavernous malformations of the brain maps to chromosome 7q, Hum. Mol. Genet., 4, 453, 10.1093/hmg/4.3.453

Dumont, 1995, Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development, Dev. Dyn., 203, 80, 10.1002/aja.1002030109

Dumont, 1994, Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo, Genes Dev., 8, 1897, 10.1101/gad.8.16.1897

Dumont, 1998, Cardiovascular failure in mouse embryos deficient in VEGF receptor-3, Science, 282, 946, 10.1126/science.282.5390.946

Eerola, 2000, KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation, Hum. Mol. Genet., 9, 1351, 10.1093/hmg/9.9.1351

Enjolras, 1990

Fachinger, 1999, Functional interaction of vascular endothelial-protein–tyrosine phosphatase with the angiopoietin receptor Tie-2, Oncogene, 18, 5948, 10.1038/sj.onc.1202992

Ferrell, 1998, Hereditary lymphedema: evidence for linkage and genetic heterogeneity, Hum. Mol. Genet., 7, 2073, 10.1093/hmg/7.13.2073

Gallione, 1995, A gene for familial venous malformations maps to chromosome 9p in a second large kindred, J. Med. Genet., 32, 197, 10.1136/jmg.32.3.197

Giombini, 1978, Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature, Acta Neurochir., 40, 61, 10.1007/BF01773116

Gougos, 1990, Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells, J. Biol. Chem., 265, 8361, 10.1016/S0021-9258(19)38892-1

Gupta, 1965, Multiple painful glomus tumors of the skin. Views on histogenesis: case report, Arch. Dermatol., 92, 670, 10.1001/archderm.1965.01600180062010

Guttmacher, 1995, Hereditary hemorrhagic telagiectasia, N. Engl. J. Med., 333, 918, 10.1056/NEJM199510053331407

Huang, 1995, GRB2 and SH-PTP2: Potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase, Oncogene, 11, 2097

Irrthum, 2000, Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase, Am. J. Hum. Genet., 67, 295, 10.1086/303019

Irrthum, 2001, Linkage disequilibrium narrows locus for venous malformations with glomus cells (VMGLOM) to a single 1.48-Mbp YAC, Eur. J. Hum. Genet., 9, 34, 10.1038/sj.ejhg.5200576

Johnson, 1996, Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nat. Genet., 13, 189, 10.1038/ng0696-189

Jones, 1998, The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R, Oncogene, 17, 1097, 10.1038/sj.onc.1202115

Jones, 1999, Identification of Tek/Tie2 binding partners. Binding To a multifunctional docking site mediates cell survival and migration, J. Biol. Chem., 274, 30896, 10.1074/jbc.274.43.30896

Kaipainen, 1995, Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development, Proc. Natl. Acad. Sci. USA, 92, 3566, 10.1073/pnas.92.8.3566

Karkkainen, 2000, Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema, Nat. Genet., 25, 153, 10.1038/75997

Kim, 2000, Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway, Circ. Res., 86, 24, 10.1161/01.RES.86.1.24

Kontos, 1998, Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt, Mol. Cell. Biol., 18, 4131, 10.1128/MCB.18.7.4131

Korpelainen, 1999, Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant TIE-2 causing venous malformations signals a distinct STAT activation response, Oncogene, 18, 1, 10.1038/sj.onc.1202288

Kräling, 1996, E-selectin is present in proliferating endothelial cells in human hemangiomas, Am. J. Pathol., 148, 1181

Labauge, 1999, An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families, Ann. Neurol., 45, 250, 10.1002/1531-8249(199902)45:2<250::AID-ANA17>3.0.CO;2-V

Laberge-le Couteulx, 1999, Truncatin mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas, Nat. Genet., 23, 189, 10.1038/13815

Maisonpierre, 1997, Angiopoietin 2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55

Mangion, 1999, A gene for lymphedema-distichiasis maps to 16q24.3, Am. J. Hum. Genet., 65, 427, 10.1086/302500

Mason, 1988, Familial cavernous angiomas of the brain in an Hispanic family, Neurology, 38, 324, 10.1212/WNL.38.2.324

McAllister, 1994, Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1, Nat. Genet., 8, 345, 10.1038/ng1294-345

Mulliken, 1982, Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics, Plast. Reconstr. Surg., 69, 412, 10.1097/00006534-198203000-00002

Mulliken, 1988

Notelet, 1997, Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: an immunocytochemical study of 42 cases, Surg. Neurol., 47, 364, 10.1016/S0090-3019(96)00248-0

Papapetropoulos, 2000, Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway, J. Biol. Chem., 275, 9102, 10.1074/jbc.275.13.9102

Pepper, 1977, Multiple glomus tumors, J. Cutaneous Pathol., 4, 244, 10.1111/j.1600-0560.1977.tb00913.x

Rigamonti, 1988, Cerebral cavernous malformations. Incidence and familial occurrence, N. Engl. J. Med., 319, 343, 10.1056/NEJM198808113190605

Rigamonti, 1991, Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity, Neurosurgery, 28, 60, 10.1227/00006123-199101000-00010

Robinson, 1995, Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis, Neurol. Res., 17, 49, 10.1080/01616412.1995.11740286

Sahoo, 1999, Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1), Hum. Mol. Genet., 8, 2325, 10.1093/hmg/8.12.2325

Sato, 1995, Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation, Nature, 376, 70, 10.1038/376070a0

Schlaeger, 1997, Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice, Proc. Natl. Acad. Sci. USA, 94, 3058, 10.1073/pnas.94.7.3058

Serebriiskii, 1997, Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat- containing protein encoded by a gene mapping to 7q21-22, Oncogene, 15, 1043, 10.1038/sj.onc.1201268

Suri, 1996, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis, Cell, 87, 1171, 10.1016/S0092-8674(00)81813-9

Suri, 1998, Increased vascularization in mice overexpressing angiopoietin-1, Science, 282, 468, 10.1126/science.282.5388.468

Takahashi, 1994, Cellular markers that distinguish the phases of hemangioma during infancy and childhood, J. Clin. Invest., 93, 2357, 10.1172/JCI117241

Takakura, 1998, Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis, Immunity, 9, 677, 10.1016/S1074-7613(00)80665-2

Vikkula, 1996, Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2, Cell, 87, 1181, 10.1016/S0092-8674(00)81814-0

Vikkula, 1998, Molecular basis of vascular anomalies, Trends Cardiovasc. Med., 8, 281, 10.1016/S1050-1738(98)00024-3

Vikkula, 1995, Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus, Cell, 80, 431, 10.1016/0092-8674(95)90493-X

Wautier, 1999, Cultured endothelial cells from human arteriovenous malformations have defective growth regulation, Blood, 94, 2020, 10.1182/blood.V94.6.2020

Witzenbichler, 1998, Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2, J. Biol. Chem., 273, 18514, 10.1074/jbc.273.29.18514

Zhang, 2000, Mutations in KRIT1 in familial cerebral cavernous malformations, Neurosurg, 46, 1272, 10.1097/00006123-200005000-00064

Zhou, 2000, Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis, Hum. Mol. Genet., 9, 765, 10.1093/hmg/9.5.765